|
1
|
Reed KE and Rice CM: Overview of hepatitis
C virus genome structure, polyprotein processing, and protein
properties. Curr Top Microbiol Immunol. 242:55–84. 2000.
|
|
2
|
Gu L, Tong W, Yuan M, Lu T, Li C and Lu L:
An increased diversity of HCV isolates were characterized among 393
patients with liver disease in China representing six genotypes, 12
subtypes, and two novel genotype 6 variants. J Clin Virol.
57:311–317. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rong X, Xu R, Xiong H, Wang M, Huang K,
Chen Q, Li C, Liao Q, Huang J, Xia W, et al: a comparison between
2004–2007 and 2008–2011. Arch Virol. 159:3231–3237. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grassi E and Aghemo A: How to optimize HCV
therapy in genotype 2 patients. Liver Int. 33(Suppl 1): 35–40.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abe H, Aida Y, Ishiguro H, Yoshizawa K,
Seki N, Miyazaki T, Itagaki M, Sutoh S, Ika M, Kato K, et al: New
proposal for response-guided peg-interferon-plus-ribavirin
combination therapy for chronic hepatitis C virus genotype 2
infection. J Med Virol. 85:1523–1533. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Inamullah, Idrees M, Ahmed H,
Sajid-ul-ghafoor, Ali M, Ali L and Ahmed A: Hepatitis C virus
genotypes circulating in district Swat of Khyber Pakhtoonkhaw,
Pakistan. Virol J. 8(16)2011.PubMed/NCBI
|
|
7
|
Chakravarti A, Ashraf A and Malik S: A
study of changing trends of prevalence and genotypic distribution
of hepatitis C virus among high risk groups in North India. Indian
J Med Microbiol. 31:354–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Verbeeck J, Maes P, Lemey P, Pybus OG,
Wollants E, Song E, Nevens F, Fevery J, Delport W, Van der Merwe S
and Van Ranst M: Investigating the origin and spread of hepatitis C
virus genotype 5a. J Virol. 80:4220–4226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu L, Nakano T, He Y, Fu Y, Hagedorn CH
and Robertson BH: Hepatitis C virus genotype distribution in China:
predominance of closely related subtype 1b isolates and existence
of new genotype 6 variants. J Med Virol. 75:538–549. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang C, Wu N, Liu J, Ge Q, Huang Y, Ren
Q, Feng Q and He G: HCV subtype characterization among injection
drug users: implication for a crucial role of Zhenjiang in HCV
transmission in China. PLoS One. 6:e168172011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Du H, Qi Y, Hao F, Huang Y, Mao L, Ji S,
Huang M, Qin C, Yan R, Zhu X and Zhang C: Complex patterns of HCV
epidemic in Suzhou: evidence for dual infection and HCV
recombination in East China. J Clin Virol. 54:207–212. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wyles DL and Gutierrez JA: Importance of
HCV genotype 1 subtypes for drug resistance and response to
therapy. J Viral Hepat. 21:229–240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fried MW, Shiffman ML, Reddy KR, Smith C,
Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G,
Dhumeaux D, et al: Peginterferon alfa-2a plus ribavirin for chronic
hepatitis C virus infection. N Engl J Med. 347:975–982. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin JA, Chen YC, Cheng SN, Chen PJ, Chu
HC, Hsieh TY and Shih YL: Peginterferon alfa-2a plus ribavirin for
hemophilic patients with chronic hepatitis C virus infection in
Taiwan. J Formos Med Assoc. 113:727–733. 2014. View Article : Google Scholar
|
|
15
|
Waheed Y, Saeed U, Anjum S, Afzal MS and
Ashraf M: Development of global consensus sequence and analysis of
highly conserved domains of the HCV NS5B protein. Hepat Mon.
12:e61422012.
|
|
16
|
Weck K: Molecular methods of hepatitis C
genotyping. Expert Rev Mol Diagn. 5:507–520. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamashita K, Ohtsuka N, Kagawa S and
Matsuoka A: Improved method for detection and subtyping of HCV.RNA
by nested polymerase chain reaction. Rinsho Byori. 43:1147–1152.
1995.In Japanese. PubMed/NCBI
|
|
18
|
Stuyver L, Rossau R, Wyseur A, Duhamel M,
Vanderborght B, Van Heuverswyn H and Maertens G: Typing of
hepatitis C virus isolates and characterization of new subtypes
using a line probe assay. J Gen Virol. 74:1093–1102. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Buoro S, Pizzighella S, Boschetto R,
Pellizzari L, Cusan M, Bonaguro R, Mengoli C, Caudai C, Padula M,
Egisto Valensin P and Palù G: Typing of hepatitis C virus by a new
method based on restriction fragment length polymorphism.
Intervirology. 42:1–8. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Simmonds P, Bukh J, Combet C, Deléage G,
Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens
G, et al: Consensus proposals for a unified system of nomenclature
of hepatitis C virus genotypes. Hepatology. 42:962–973. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cai Q, Zhao Z, Liu Y, Shao X and Gao Z:
Comparison of three different HCV genotyping methods: Core, NS5B
sequence analysis and line probe assay. Int J Mol Med. 31:347–352.
2013.
|
|
22
|
Modi AA and Liang TJ: Hepatitis C: a
clinical review. Oral Dis. 14:10–14. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Asselah T and Marcellin P: New
direct-acting antivirals' combination for the treatment of chronic
hepatitis C. Liver Int. 31(Suppl 1): 68–77. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rao H, Wei L, Lopez-Talavera JC, Shang J,
Chen H, Li J, Xie Q, Gao Z, Wang L, Wei J, et al: Distribution and
clinical correlates of viral and host genotypes in Chinese patients
with chronic hepatitis C virus infection. J Gastroenterol Hepatol.
29:545–553. 2014. View Article : Google Scholar :
|
|
25
|
Ashfaq UA, Javed T, Rehman S, Nawaz Z and
Riazuddin S: An overview of HCV molecular biology, replication and
immune responses. Virol J. 8(161)2011. View Article : Google Scholar
|
|
26
|
Zein NN: Clinical significance of
hepatitis C virus genotypes. Clin Microbiol Rev. 13:223–235. 2000.
View Article : Google Scholar
|
|
27
|
Chevaliez S, Bouvier-Alias M, Brillet R
and Pawlotsky JM: Hepatitis C virus (HCV) genotype 1 subtype
identification in new HCV drug development and future clinical
practice. PLoS One. 4:e82092009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jang JY and Chung RT: New treatments for
chronic hepatitis C. Korean J Hepatol. 16:263–277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu J, Tao W, Li R, Xiang Y, Zhang N, Xiang
X, Xie Q and Zhong J: Construction and characterization of
infectious hepatitis C virus chimera containing structural proteins
directly from genotype 1b clinical isolates. Virology. 443:80–88.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou X, Chan PK, Tam JS and Tang JW: A
possible geographic origin of endemic hepatitis C virus 6a in Hong
Kong: Evidences for the association with Vietnamese immigration.
PLoS One. 6. pp. e248892011, View Article : Google Scholar
|
|
31
|
Tao J, Liu J, Pu D and Lei H: Efficacy of
interferon alpha with ribavirin for treatment of chronic hepatitis
C. Zhonghua Gan Zang Bing Za Zhi. 19:683–685. 2011.PubMed/NCBI
|
|
32
|
Wendt A, Adhoute X, Castellani P, Oules V,
Ansaldi C, Benali S and Bourlière M: Chronic hepatitis C: future
treatment. Clin Pharmacol. 6:1–17. 2014.PubMed/NCBI
|
